Skip to main content
. 2023 Apr 11;24(8):7048. doi: 10.3390/ijms24087048

Figure 15.

Figure 15

(A–F) Percentage of CD8 effector cells producing IFN-γ, IL-10, IL-17, IL-9, TNF-α, and IL-2 in healthy controls (HC); chronic SCI patients with short periods of evolution (<5 years) (SCI-SP); chronic SCI patients in early chronic phase (5 to 15 years) (SCI-ECP); and chronic SCI patients in late-chronic phase >15 years) (SCI-LCP). We use ‘*’ to distinguish between chronic SCI patients and HC, whereas ‘+’ is used to compare chronic SCI patients. p < 0.05 (*/+), p < 0.01 (**), and p < 0.001 (***).